Stories tagged 'HIV superinfection'
25 powerful years of HIV research
Longstanding Mombasa Cohort helps answer questions about HIV risk and transmission
Feb. 26, 2018 | By Sabrina Richards / Fred Hutch News Service
For 25 years, Fred Hutch virologist Dr. Julie Overbaugh has helped lead the Mombasa Cohort, a unique group of women at high risk for HIV transmission.
Good News at Fred Hutch
Dr. Rainer Storb receives $12.9M to study blood stem-cell therapies for immune deficiencies; Dr. Julie Overbaugh studies HIV 'superinfection' to provide clues for better vaccine design
July 9, 2015 | By Fred Hutch staff
Dr. Rainier Storb receives $12.9M to study stem-cell therapies for immune deficiencies; Dr. Julie Overbaugh studies HIV 'superinfection' to provide clues for better vaccine design
HIV 'superinfection' boosts immune response
Overbaugh, Cortez-led study shows women infected by two different HIV strains exhibit strong antibody response; findings may aid vaccine development
April 2, 2012 | By Kristen Woodward
Researchers at the Fred Hutchinson Cancer Research Center found that women who have been infected by two different strains of HIV from two different sexual partners-a condition known as HIV superinfection-have more potent antibody responses that block the replication of the virus compared to women who've only been infected once.
(RSS feeds are best viewed in browsers other than Chrome)
Editor's Picks
Six misconceptions about colorectal cancer
Luke Timmerman to scale Mount Everest for Fred Hutch research
A message from Dr. Gary Gilliland about cancer research in 2018
GIVE NOW &
SAVE LIVES
Story Archive
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
Publications
Magazine Archive
Back issues of Hutch Magazine
Financial Reporting
Fiscal highlights & Annual Reports
Science Spotlight
Monthly review of Center-authored papers
Fred Hutch News
Get updates via email.
